Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Medicago
Biotech
Next-gen COVID shots need differentiation, pan-variant potential
Next-gen COVID shots from Sanofi/GSK, Gritstone, Valneva and others will need to be different from current shots, plus easy to scale up in production.
Annalee Armstrong
,
Kyle LaHucik
Jan 24, 2022 10:53am
GlaxoSmithKline, Medicago hit 75% efficacy against delta
Dec 7, 2021 7:00am
Medicago, GSK post data on plant-derived COVID-19 vaccine
May 18, 2021 5:21am
GSK kick-starts phase 3 Medicago-partnered COVID vaccine test
Mar 16, 2021 8:30am
GlaxoSmithKline pens COVID-19 vaccine pact with Medicago
Jul 7, 2020 8:55am